뎅기열 검사 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2031년) - 제품 유형별, 최종사용자별, 지역별

Dengue Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

US $ 4,995 ￦ 7,055,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 11,999,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 14,972,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

뎅기열의 전 세계 발병률은 빠르게 증가하고 있으며, 아프리카, 아메리카, 동지중해, 동남아시아, 서태평양 등 주요 지역에서 큰 영향을 미치고 있습니다. 세계보건기구(WHO)는 뎅기열 환자의 지속적인 증가를 보고하고 있으며, 효과적인 진단 솔루션의 시급한 필요성을 강조하고 있습니다.

아메리카에서 뎅기열의 유행이 우려할 만한 수준에 이르렀고, 수백만 명의 환자가 보고되고 있습니다. 브라질이 핫스팟으로 떠오르며 이들 중 상당수를 차지하고 있습니다. 브라질의 뎅기열 감염자 급증은 건강 위기의 심각성을 강조하고 있으며, 이전 수치에 비해 크게 증가했습니다.

서태평양 지역에서도 상당수의 뎅기열 의심 환자가 발생하고 있습니다. 필리핀과 말레이시아가 가장 큰 영향을 받은 국가 중 하나이며, 두 국가 모두 높은 환자 수를 보고하고 있습니다. 이들 지역에서는 뎅기열 바이러스의 확산으로 인해 적시에 정확한 진단을 위해 필수적인 진단 키트에 대한 수요가 증가하고 있습니다.

기후 변화로 인해 전 세계적으로 뎅기열 유행이 악화되고 있습니다. 최근 뎅기열, 치쿤구니아와 웨스트나일 바이러스가 이전에 영향을 받지 않았던 국가에서 발생한 것은 지구 온난화가 가져올 수 있는 잠재적 위협을 잘 보여주고 있습니다. 기후 변화는 유럽을 포함한 다양한 지역에서 현재와 미래의 위험을 증가시키고 있으며, 매개 모기의 분포와 잠재적 질병 전파에 큰 영향을 미치고 있습니다.

이 보고서는 세계 뎅기열 검사 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 최종사용자별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 경제 개요
• PESTLE 분석

제3장 세계의 뎅기열 검사 시장 전망, 2018-2031년

• 세계의 뎅기열 검사 시장 전망, 제품 유형별, 금액(10억 달러), 2018-2031년
• 세계의 뎅기열 검사 시장 전망, 최종사용자별, 금액(10억 달러), 2018-2031년
• 세계의 뎅기열 검사 시장 전망, 지역별, 금액(10억 달러), 2018-2031년

제4장 북미의 뎅기열 검사 시장 전망, 2018-2031년

제5장 유럽의 뎅기열 검사 시장 전망, 2018-2031년

제6장 아시아태평양의 뎅기열 검사 시장 전망, 2018-2031년

제7장 라틴아메리카의 뎅기열 검사 시장 전망, 2018-2031년

제8장 중동 및 아프리카의 뎅기열 검사 시장 전망, 2018-2031년

제9장 경쟁 상황

• 제품별과 최종사용자별 히트맵
• 기업 시장 점유율 분석, 2023년
• 경쟁 대시보드
• 기업 개요
  • Thermo Fisher Scientific Inc.
  • Roche Molecular Systems Inc.
  • Abbott Laboratories
  • InBios International, Inc.
  • NovaTec Immundiagnostica GmbH
  • Quest Diagnostics
  • Certest Biotec S.L.
  • OriGene Technologies
  • Abnova Corporation
  • 기타

제10장 부록

ksm

영문 목차

영문목차

The global incidence of dengue has been increasing rapidly, with significant impacts across major regions including Africa, the Americas, the Eastern Mediterranean, Southeast Asia, and the Western Pacific. The World Health Organization (WHO) reports a continuous rise in dengue cases, highlighting the urgent need for effective diagnostic solutions.

Rising Dengue Cases Across the Globe

Americas

In the Americas, the prevalence of dengue has reached alarming levels, with millions of reported cases. Brazil has emerged as a hotspot, contributing a substantial portion of these cases. The surge in dengue cases in Brazil underscores the growing health crisis, with a significant increase compared to previous figures.

Western Pacific Region

The Western Pacific region has also witnessed a significant number of suspected dengue cases. The Philippines and Malaysia are among the most affected countries, both reporting high case numbers. This escalating prevalence of the dengue virus in these regions is driving the demand for diagnostic kits, crucial for timely and accurate detection.

Climate Change and Dengue Fever

Impact of Climate Change

Climate change is exacerbating the prevalence of dengue fever worldwide. Recent outbreaks of dengue, chikungunya, and West Nile virus in previously unaffected countries highlight the potential threats posed by global warming. Changes in climate have heightened current and future risks in various regions, including Europe, significantly impacting vector distribution and potential disease transmission.

Environmental Factors

Environmental factors such as high rainfall and humidity create favorable breeding conditions for mosquitoes. Additionally, curtailed water supply and disrupted sanitation services facilitate mosquito proliferation, while warm temperatures extend the active season for these vectors. These climatic changes are likely to increase the burden of dengue fever, subsequently driving the growth of the dengue testing market.

Innovations in Dengue Testing

Need for Cost-Effective Diagnostic Kits

Currently, the available diagnostic test kits for dengue are less effective, creating a need for cost-effective kits with high specificity and sensitivity. The high price and limited effectiveness of existing test kits have prompted companies to focus on developing reliable and affordable diagnostic methods. Increasing research and development activities aim to produce highly specific and sensitive diagnostic kits, opening new growth opportunities for manufacturers.

Development of Point-of-Care Tests

Manufacturers are prioritizing the development of point-of-care tests that are rapid, sensitive, and easy to use. Many existing methods for detecting the dengue virus rely on cell culture and mice inoculation, which are slow and expensive. There is a pressing need for rapid, user-friendly, and sensitive detection methods to enhance the efficiency of dengue diagnosis.

Global Dengue Testing Market by Region

Dominance of Asia Pacific

The Asia Pacific region has been at the forefront of the global dengue testing market in terms of revenue. This trend is expected to continue, with Asia Pacific projected to remain the most attractive market for dengue testing. The region's significant share in the global dengue testing market underscores its critical role in addressing the dengue epidemic.

Key Market Players Include:

• Abnova Corporation
• Roche Molecular Systems Inc.
• Abbott Laboratories
• InBios International, Inc.
• NovaTec Immundiagnostica GmbH
• Euroimmun AG (Sub. PerkinElmer)
• Quest Diagnostics
• Certest Biotec S.L.
• OriGene Technologies
• Thermo Fisher Scientific Inc.
• Others.

Global Dengue Testing Market Segmentation:

By Product Type:

• Premium
• Mid
• Low

By End User:

• Hospitals
• Public Health Laboratory
• Diagnostic Centers
• Others

By Region:

• China
• India
• Japan
• Indonesia
• South Korea
• Rest of Asia Pacific

Table of Contents

1. Executive Summary

• 1.1. Global Dengue Testing Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2023
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Economic Overview
  • 2.6.1. World Economic Projections
• 2.7. PESTLE Analysis

3. Global Dengue Testing Market Outlook, 2018 - 2031

• 3.1. Global Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
  • 3.1.1. Key Highlights
    • 3.1.1.1. ELISA-based Tests
    • 3.1.1.2. RT-PCR based Tests
    • 3.1.1.3. Dengue IgG/IgM Rapid Test
• 3.2. Global Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 3.2.1. Key Highlights
    • 3.2.1.1. Hospitals
    • 3.2.1.2. Public Health Laboratory
    • 3.2.1.3. Diagnostic Centers
    • 3.2.1.4. Others
• 3.3. Global Dengue Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
  • 3.3.1. Key Highlights
    • 3.3.1.1. North America
    • 3.3.1.2. Europe
    • 3.3.1.3. Asia Pacific
    • 3.3.1.4. Latin America
    • 3.3.1.5. Middle East & Africa

4. North America Dengue Testing Market Outlook, 2018 - 2031

• 4.1. North America Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
  • 4.1.1. Key Highlights
    • 4.1.1.1. ELISA-based Tests
    • 4.1.1.2. RT-PCR based Tests
    • 4.1.1.3. Dengue IgG/IgM Rapid Test
• 4.2. North America Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 4.2.1. Key Highlights
    • 4.2.1.1. Hospitals
    • 4.2.1.2. Public Health Laboratory
    • 4.2.1.3. Diagnostic Centers
    • 4.2.1.4. Others
• 4.3. North America Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
  • 4.3.1. Key Highlights
    • 4.3.1.1. U.S. Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.3.1.2. U.S. Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.1.3. Canada Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.3.1.4. Canada Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Dengue Testing Market Outlook, 2018 - 2031

• 5.1. Europe Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. ELISA-based Tests
    • 5.1.1.2. RT-PCR based Tests
    • 5.1.1.3. Dengue IgG/IgM Rapid Test
• 5.2. Europe Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Hospitals
    • 5.2.1.2. Public Health Laboratory
    • 5.2.1.3. Diagnostic Centers
    • 5.2.1.4. Others
• 5.3. Europe Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Germany Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.3.1.2. Germany Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1.3. U.K. Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.3.1.4. U.K. Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1.5. France Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.3.1.6. France Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1.7. Italy Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.3.1.8. Italy Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1.9. Turkey Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.3.1.10. Turkey Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1.11. Russia Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.3.1.12. Russia Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1.13. Rest of Europe Dengue Testing Market by Product Type, Value (US$Bn), 2018 - 2031
    • 5.3.1.14. Rest of Europe Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Dengue Testing Market Outlook, 2018 - 2031

• 6.1. Asia Pacific Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. ELISA-based Tests
    • 6.1.1.2. RT-PCR based Tests
    • 6.1.1.3. Dengue IgG/IgM Rapid Test
• 6.2. Asia Pacific Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Hospitals
    • 6.2.1.2. Public Health Laboratory
    • 6.2.1.3. Diagnostic Centers
    • 6.2.1.4. Others
  • 6.2.2. BPS Analysis/Market Attractiveness Analysis
• 6.3. Asia Pacific Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. China Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.3.1.2. China Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1.3. Japan Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.3.1.4. Japan Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1.5. South Korea Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.3.1.6. South Korea Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1.7. India Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.3.1.8. India Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1.9. Southeast Asia Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.3.1.10. Southeast Asia Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1.11. Rest of Asia Pacific Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.3.1.12. Rest of Asia Pacific Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Dengue Testing Market Outlook, 2018 - 2031

• 7.1. Latin America Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
  • 7.1.1. Key Highlights
    • 7.1.1.1. ELISA-based Tests
    • 7.1.1.2. RT-PCR based Tests
    • 7.1.1.3. Dengue IgG/IgM Rapid Test
• 7.2. Latin America Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 7.2.1.1. Hospitals
  • 7.2.1.2. Public Health Laboratory
  • 7.2.1.3. Diagnostic Centers
  • 7.2.1.4. Others
  • 7.2.2. BPS Analysis/Market Attractiveness Analysis
• 7.3. Latin America Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
  • 7.3.1. Key Highlights
    • 7.3.1.1. Brazil Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.3.1.2. Brazil Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.1.3. Mexico Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.3.1.4. Mexico Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.1.5. Argentina Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.3.1.6. Argentina Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.1.7. Rest of Latin America Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.3.1.8. Rest of Latin America Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Dengue Testing Market Outlook, 2018 - 2031

• 8.1. Middle East & Africa Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
  • 8.1.1. Key Highlights
    • 8.1.1.1. ELISA-based Tests
    • 8.1.1.2. RT-PCR based Tests
    • 8.1.1.3. Dengue IgG/IgM Rapid Test
• 8.2. Middle East & Africa Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 8.2.1. Key Highlights
    • 8.2.1.1. Hospitals
    • 8.2.1.2. Public Health Laboratory
    • 8.2.1.3. Diagnostic Centers
    • 8.2.1.4. Others
  • 8.2.2. BPS Analysis/Market Attractiveness Analysis
• 8.3. Middle East & Africa Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
  • 8.3.1. Key Highlights
    • 8.3.1.1. GCC Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.3.1.2. GCC Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.1.3. South Africa Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.3.1.4. South Africa Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.1.5. Egypt Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.3.1.6. Egypt Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.1.7. Nigeria Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.3.1.8. Nigeria Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.1.9. Rest of Middle East & Africa Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.3.1.10. Rest of Middle East & Africa Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. By Product vs by End User Heatmap
• 9.2. Company Market Share Analysis, 2023
• 9.3. Competitive Dashboard
• 9.4. Company Profiles
  • 9.4.1. Thermo Fisher Scientific Inc.
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Therapy Portfolio
    • 9.4.1.3. Financial Overview
    • 9.4.1.4. Business Strategies and Development
  • 9.4.2. Roche Molecular Systems Inc.
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Therapy Portfolio
    • 9.4.2.3. Financial Overview
    • 9.4.2.4. Business Strategies and Development
  • 9.4.3. Abbott Laboratories
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Therapy Portfolio
    • 9.4.3.3. Financial Overview
    • 9.4.3.4. Business Strategies and Development
  • 9.4.4. InBios International, Inc.
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Therapy Portfolio
    • 9.4.4.3. Financial Overview
    • 9.4.4.4. Business Strategies and Development
  • 9.4.5. NovaTec Immundiagnostica GmbH
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Therapy Portfolio
    • 9.4.5.3. Financial Overview
    • 9.4.5.4. Business Strategies and Development
  • 9.4.6. Quest Diagnostics
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Therapy Portfolio
    • 9.4.6.3. Financial Overview
    • 9.4.6.4. Business Strategies and Development
  • 9.4.7. Certest Biotec S.L.
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Therapy Portfolio
    • 9.4.7.3. Financial Overview
    • 9.4.7.4. Business Strategies and Development
  • 9.4.8. OriGene Technologies
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Therapy Portfolio
    • 9.4.8.3. Financial Overview
    • 9.4.8.4. Business Strategies and Development
  • 9.4.9. Abnova Corporation
    • 9.4.9.1. Company Overview
    • 9.4.9.2. Therapy Portfolio
    • 9.4.9.3. Financial Overview
    • 9.4.9.4. Business Strategies and Development
  • 9.4.10. Others
    • 9.4.10.1. Company Overview
    • 9.4.10.2. Therapy Portfolio
    • 9.4.10.3. Financial Overview
    • 9.4.10.4. Business Strategies and Development

10. Appendix

• 10.1.Research Methodology
• 10.2.Report Assumptions
• 10.3.Acronyms and Abbreviations

관련자료